Christopher Doherty
Direktor/Vorstandsmitglied bei Infex Therapeutics Ltd.
Profil
Christopher Doherty is a Non-Executive Director at AMR Centre Ltd.
and a Director at Infex Therapeutics Holdings PLC.
He was previously a Director at Alderley Park Holdings Ltd.
and Managing Director & Director at Alderley Park Ltd.
He also served as a Director at BiVictriX Therapeutics Plc for a brief period in 2018.
Doherty holds a doctorate from the University of Bradford, an MBA from the University of Toronto, and an undergraduate degree from the School of Pharmacy.
Aktive Positionen von Christopher Doherty
| Unternehmen | Position | Beginn |
|---|---|---|
Infex Therapeutics Ltd.
 Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Direktor/Vorstandsmitglied | - |
Infex Therapeutics Holdings Plc
 Infex Therapeutics Holdings Plc Miscellaneous Commercial ServicesCommercial Services Infex Therapeutics Holdings PLC is a British biotechnology company founded in 2022. The company is based in Milton Keynes, UK. The company is engaged in research and experimental development in the field of biotechnology. | Direktor/Vorstandsmitglied | 06.04.2022 |
Ehemalige bekannte Positionen von Christopher Doherty
| Unternehmen | Position | Ende |
|---|---|---|
Alderley Park Holdings Ltd.
 Alderley Park Holdings Ltd. Financial ConglomeratesFinance Alderley Park Holdings Ltd. functions as an investment holding company. The company was founded on January 14, 2014 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 30.09.2019 |
| BIVICTRIX THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 20.10.2018 |
Alderley Park Ltd.
 Alderley Park Ltd. Other Consumer ServicesConsumer Services Part of Bruntwood SciTech Ltd., Alderley Park Ltd. is a science and technology community located in Macclesfield, UK. Alderley Park offers bioscience facilities for R&D focused life science companies, flexible tech workspaces, and a vibrant community with a range of leisure activities. The British company has invested £247m in 400 acres of land, providing 1m sq.ft. of space for 2 national institutions and 2500 innovators. With a dedicated business support service and shared scientific services, Alderley Park is an ideal place to support pioneering innovation. The company was founded in 2013 and Kathleen Phillippa Mackay has been the CEO of the company since 2019. | Vorstandsvorsitzender | 11.10.2019 |
Ausbildung von Christopher Doherty
| University of Bradford | Doctorate Degree |
| University of Toronto | Masters Business Admin |
| School of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Alderley Park Holdings Ltd.
Alderley Park Holdings Ltd. Financial ConglomeratesFinance Alderley Park Holdings Ltd. functions as an investment holding company. The company was founded on January 14, 2014 and is headquartered in Manchester, the United Kingdom. | Finance |
Infex Therapeutics Ltd.
Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Health Technology |
Alderley Park Ltd.
Alderley Park Ltd. Other Consumer ServicesConsumer Services Part of Bruntwood SciTech Ltd., Alderley Park Ltd. is a science and technology community located in Macclesfield, UK. Alderley Park offers bioscience facilities for R&D focused life science companies, flexible tech workspaces, and a vibrant community with a range of leisure activities. The British company has invested £247m in 400 acres of land, providing 1m sq.ft. of space for 2 national institutions and 2500 innovators. With a dedicated business support service and shared scientific services, Alderley Park is an ideal place to support pioneering innovation. The company was founded in 2013 and Kathleen Phillippa Mackay has been the CEO of the company since 2019. | Consumer Services |
Infex Therapeutics Holdings Plc
Infex Therapeutics Holdings Plc Miscellaneous Commercial ServicesCommercial Services Infex Therapeutics Holdings PLC is a British biotechnology company founded in 2022. The company is based in Milton Keynes, UK. The company is engaged in research and experimental development in the field of biotechnology. | Commercial Services |